This article was originally published in The Gray Sheet
Limited rollout of its cardioplagia safety system (CSS) for use during stopped-heart coronary artery bypass surgery commences following 510(k) clearance May 4, the firm reports. The device "controls potassium flow level and dilution, monitors flow pressure and guards against air in the line" after blood flow through the aorta is stopped and potassium is delivered to arrest the heartbeat, Medtronic says in a May 12 release. The CSS features reduce the incidence of accidental vessel rupture due to over pressurization, the firm claims...
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.